ArticleAdvances in therapy2022

Real-World Biologic Adherence, Persistence, and Monotherapy Comparisons in US Patients with Psoriasis: Results from IBM MarketScan

Craig Leonardi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.